{"product_id":"biolegend-125226","title":"Biolegend, 125226, PE\/Cyanine7 anti-mouse CD223 (LAG-3) Antibody, 100μg","description":"\u003cp\u003eCD223, also known as LAG-3, is 70 kD type I transmembrane glycoprotein within the Ig superfamily. It is the gene product of lymphocyte activation gene-3 (Lag3) with structural similarity to CD4. CD223 is expressed on activated T cells and NK cells, as well as T regulatory cells. CD223, like CD4, binds MHC class II molecules, but with higher affinity than CD4. In association with the CD3 complex, CD223 has been shown as a negative regulatory molecule to inhibit TCR-mediated signaling and regulate homeostatic T cell expansion. In contrast to inhibition, CD223 has an activation function to promote immune responses by inducing MHC class II signaling in antigen presenting cells.\u003cbr\u003e\n100μg\u003cbr\u003e\nVerified Reactivity: Mouse\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Rat\u003cbr\u003e\nImmunogen: Murine CD223-Ig fusion protein\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography and conjugated with PE\/Cyanine7 under optimal conditions.\u003cbr\u003e\nConcentration: 0.2 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)Green Laser (532 nm)\/Yellow-Green Laser (561 nm)\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Workman CJ, et al. 2002. Eur. Immunol. 32:2255. (IP, ELISA) Workman CJ, et al. 2005. J. Immunol. 174:688. (FC) Li N, et al. 2004. J. Immunol. 173:6806. (IP, ELISA)\u003cbr\u003e\nProduct Citations: Ivasko SM, et al. 2023. Front Immunol. 13:1023206. PubMed Wu M, et al. 2021. Nat Commun. 12:3500. PubMed Cribioli E, et al. 2022. Front Immunol. 13:976628. PubMed Pein M, et al. 2020. Nat Commun. 11:1494. PubMed He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed Sun M, et al. 2021. J Immunother Cancer. 9:. PubMed Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed He X, et al. 2021. J Immunother Cancer. 9:. PubMed Molgora M, et al. 2020. Cell. 182:886. PubMed Truckenbrod EN, et al. 2021. Elife. 10:. PubMed Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed Habener A, et al. 2021. J Allergy Clin Immunol. 147:2281. PubMed\u003cbr\u003e\nRRID: AB_2715763 (BioLegend Cat. No. 125225) AB_2715764 (BioLegend Cat. No. 125226)\u003cbr\u003e\nStructure: Ig superfamily\u003cbr\u003e\nDistribution: T cells and NK cells, as well as T regulatory cells\u003cbr\u003e\nCell Type: NK cells, T cells, Tregs\u003cbr\u003e\nBiology Area: Immunology, Inhibitory Molecules\u003cbr\u003e\nMolecular Family: Adhesion Molecules, CD Molecules\u003cbr\u003e\nAntigen References: 1. Baixeras E et al. 1992. J. Exp. Med. 176:327.\u003cbr\u003e\nGene ID: 16768\u003cbr\u003e\nUniProt: View information about CD223 on UniProt.org\u003cbr\u003e\nClone: C9B7W\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: LAG3, LAG-3\u003cbr\u003e\nIsotype: Rat IgG1, κ\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46862957707433,"sku":"125226","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/ar\/products\/biolegend-125226","provider":"Iright","version":"1.0","type":"link"}